- Book Chapter
- 10.1007/978-981-95-1357-4_41
Improving E-commerce Sentiment Analysis with mBERT and Attention-Augmented GRU
- Jan 01, 2026
- Santhi Bharath Punati + 3 more +3
Publications from 2021 to 2026
Showing 10 of 182 papers
Improving E-commerce Sentiment Analysis with mBERT and Attention-Augmented GRU
Mass stranding of the scyphozoan jellyfish Cyanea capillata at Kames Bay, Isle of Cumbrae, Scotland
Stranded jellyfish are well known to beach-combers on British beaches in summer.There are five common species in our inshore waters (Trewhella & Hatcher, 2015) but occasional incursions of oceanic waters may bring more exotic species to our shores (O'Reilly & Semler, 2020).Although jellyfish can actively swim, adverse weather can drive them ashore resulting in spectacular mass strandings.This note records an unusual mass stranding of hundreds of lion's-mane jellyfish (Cyanea capillata; Cnidaria, Scyphozoa) of various sizes on the strandline at Kames Bay, Isle of Cumbrae, Scotland, which appeared overnight on 29th/30th August 2025 (Fig. 1).Having lived on the Isle of Cumbrae for over 50 years, I have never before witnessed such large numbers of this species being washed up on Kames Bay.A few milky white specimens of another scyphozoan -the barrel jellyfish Rhizostoma octopus -were also evident among the mass of red-brown C. capillata but represented under 1% of the strandings.
Read morePSVIII-8 Evaluation of barley protein in adult dog diets and the impact on digestibility, stool quality, and palatability.
Abstract Barley protein concentrate (BP) is a new (>55% protein) ingredient that is being commercialized for use in pet foods. In this study, we evaluated the impact of BP dietary inclusion on nutrient digestibility, stool quality, and palatability in adult dogs. The high-protein, chicken-based test diets were formulated to include BP at 5% or 10%, substituting pea protein, to match protein, fat, and crude fiber. Diets were formulated to meet AAFCO Adult Maintenance ranges. The study was approved and followed by the facility’s Institutional Animal Care and Use Committee. The palatability assessment consisted of a 2-bowl preference test over a 2-day period (n=30 each) to determine intake ratio (IR) between test diets (5% and 10% BP) and vs. control. Total tract nutrient digestibility was evaluated (N=6 per diet) with 5 days of diet acclimation followed by 5 days of total fecal collection. Fecal samples were scored to assess stool quality on a 1-5 scale, where 1= nonformed/ diarrhea and 5=hard formed. Digestibility and stool quality data were analyzed by Mixed procedure of SAS 9.4 (SAS Inst. Inc., Gary, NC), with treatment as the fixed effect. An LSMEANS statement was used to calculate the least square means for each treatment with Tukey-Kramer adjustment for multiple comparison among treatments. With P < 0.05 considered statistically significant, no differences were observed between diets for dry matter digestibility (all > 77%). Crude protein digestibility (all > 80%) was similar for 5% vs control, but 10% BP inclusion tended to be lower than control (P < 0.053). Fat digestibility was slightly higher (P < 0.05) for 5% inclusion (93.9%) vs. control (92.7%) and 10% inclusion (92.3%) (P < 0.05). Stool scores were similar between groups (all averages between 3.3-3.5). The 5% BP diet had similar palatability relative to control (IR=57:43, 5% BP vs. control). However, we observed that 10% BP inclusion had lower palatability compared to control (64:36, 10% BP vs. control; P < 0.05), with no significant difference found for 5% vs 10% (58:42, 5% BP vs. 10%; P > 0.10). In summary, small changes were observed for digestibility but not stool quality with BP inclusion of up to 10%. However, palatability may be impacted at higher inclusion levels in adult dog diets.
Read moreThere's a Lordless Power in My House! Thinking Theologically about Television
Television feels like an inescapable part of daily life. From billboards to buses to pop-up ads strewn throughout the internet to that go-to conversation question, ‘Have you watched [insert name of TV show] lately?’, TV is our very present companion on this earthly pilgrimage. But where does it fit within the life of Christian discipleship? This article will explore this issue by providing a description of TV within the theological context of the lordless powers, specifically, as the base of operation for a lordless power. While this is not an entirely new insight, accounts that connect TV to the lordless powers tend to skim over the theological bedrock required to make such a claim. The challenge of this article is to provide a thicker account of the lordless activity operative in the everyday activity of watching TV, a task pursued through extended engagements with Karl Barth's theology of the lordless powers and Albert Borgmann's philosophy of technology.
Read moreIndex
a AB2 antibody-specific structure model 151 Absorption, distribution, metabolism, and excretion (ADME) 86-87, 385 Absorption, distribution, metabolism, excretion, and toxicity (ADMET) 321, 322 Acoustic ejection MS (AEMS) 224 Active pharmaceutical ingredient (API) 389 Activity-based probe profiling (ABPP) 367 Activity-based probes (ABPs) 367 Activity-based proteome profiling (ABPP) 372 Adeno-associated viruses (AAV) 131, 279, 321, 332, 403 Adoptive cell therapy/transfer (ACT) 262, 332 Affinity capillary electrophoresis mass spectrometry (ACE-MS) 76, 78 Affinity-capture self-interaction nanoparticle spectroscopy (AC-SINS) 227 Affinity chromatography mass spectrometry (AC-MS) 76, 77 Affinity purification (AP) 322 Affinity purification mass spectrometry (AP-MS) 290-293 Aggregation-prone regions (APR) 151 Agilent RapidFire (RF)-MS system 224 AlphaFold structural model 4, 37, 151, 307 Alzheimer's disease (AD) 403 AMBER 150 Amphipols 347 Anion exchange (AEX) method 75 Antibody-based PROTACs (AbTACs) 302, 327, 329 Antibody-based therapies 1 Antibody-dependent cell-mediated cytotoxicity (ADCC) 75, 77, 185-186, 321 Antibody-dependent cellular phagocytosis (ADCP) 75 Antibody-drug conjugates (ADCs) 30, 197, 327, 330, 413, 414 Antibody oligonucleotide conjugates (AOC) 413 Antibody-specific structure models 151 Anti-drug antibody (ADA) 3, 13, 19, 20 assay development challenges and considerations 201 assays employed to assess immunogenicity risk 202 clinical impact of 201-202 clinical monitoring 200-201 harmonization 201 integrating immunogenicity assessments 201 T-cell epitopes 199-200 Anti-epithelial cell adhesion molecule (EpCAM) 9 Anti-sense oligonucleotides (ASOs) 274-276, 406-407 Artificial intelligence (AI) 4 Ascorbate peroxidase (APEX) 370 Ascorbate peroxidase 2 (APEX2) 296 Atomistic simulations 151 Autophagy targeting chimeras (AUTACs and AUTOTACs)
Read moreImproved Recognition of the Nutrition and Health Benefits of Nuts and Seeds Within the Health Star Rating System
Background: The health benefits associated with the consumption of nuts and seeds are well established, yet this food group is known to be the furthest from the recommended intake; therefore, actions aiming to increase nut intake are needed. The main front-of-pack communication device in Australia, the Health Star Rating (HSR), inadvertently penalises nuts with negative points associated with energy and saturated fat content. Methods: This study aims to suggest options to policy makers by (i) examining how the HSR rates a sample of 82 nuts, seeds and products containing them and (ii) testing three sets of moderate adjustments of the HSR algorithm on the sampled products: discounting the energy from nuts and seeds (S1), discounting the saturated fat from nuts and seeds (S2) and applying an adapted algorithm based on that for ‘oils and spreads’ for foods with ≥50% nuts and seeds (S3). Results: All three scenarios improved the Spearman correlation between the HSR score and the nut and seed content (−0.80, −0.75 and −0.71 for S1, S2 and S3, respectively) compared to the original HSR (−0.66). Products with more than 50% of their weight being nuts and seeds benefited much more from these adjustments than those below 50%. For all scenarios, but most clearly for S3, the products that had a lower HSR score than the original HSR (the healthier products) benefited more from the changes brought about by the adjusted algorithms than those of lower nutritional quality. The HSR of foods that contained no nuts or seeds remained unchanged. Conclusions: With minor changes to the HSR algorithm, nut and seed products could be brought into alignment with the current evidence, encouraging their regular inclusion in dietary patterns, which could help guide consumers at the supermarket shelf.
Read moreToward a science-based classification of processed foods to support meaningful research and effective health policies.
Processed foods have been part of the American diet for decades, with key roles in providing a safe, available, affordable, and nutritious food supply. The USDA Food Guides beginning in 1916 and the US Dietary Guidelines for Americans (DGA) since 1980 have included various types of commonly consumed processed foods (e.g., heated, fermented, dried) as part of their recommendations. However, there are multiple classification systems based on "level" of food processing, and additional evidence is needed to establish the specific properties of foods classified as "highly" or "ultra"-processed (HPF/UPFs). Importantly, many foods are captured under HPF/UPF definitions, ranging from ready-to-eat fortified whole grain breakfast cereals to sugar-sweetened beverages and baked goods. The consequences of implementing dietary guidance to limit all intake of foods currently classified as HPF/UPF may require additional scrutiny to evaluate the impact on consumers' ability to meet daily nutrient recommendations and to access affordable food, and ultimately, on health outcomes. Based on a meeting held by the Institute for the Advancement of Food and Nutrition Sciences in May 2023, this paper provides perspectives on the broad array of foods classified as HPF/UPFs based on processing and formulation, including contributions to nutrient intake and dietary patterns, food acceptability, and cost. Characteristics of foods classified as UPF/HPFs are considered, including the roles and safety approval of food additives and the effect of food processing on the food matrix. Finally, this paper identifies information gaps and research needs to better understand how the processing of food affects nutrition and health outcomes.
Read moreAbstract 1345: NAV-201, an orally bioavailable small molecule NK cell activator enhancing antibody-mediated cancer therapies
Abstract Tumors employ a number of mechanisms to suppress a patient’s immune anti-tumor responses. Recently, we uncovered an immunosuppression mechanism that tumors employ to avoid humoral immune responses that involves tumor-produced proteins, called Humoral Immuno-Oncology (HIO) factors. These HIO factors are able to suppress antibody-mediated tumor cell killing via direct binding to antibodies that alter their Fc domain interactions with the C1q protein to suppress complement dependent cytotoxicity (CDC) and reduce antibody engagement with CD16a Fc receptors on immune-effector cells, including NK cells, to suppress antibody dependent cellular cytotoxicity (ADCC). HIO factor immunosuppression of ADCC appears to involve the reduced binding affinity of antibody to CD16a Fc receptors. In an attempt to identify agents that may enhance antibody-CD16a binding affinity to overcome HIO factor immunosuppression, we sought to identify agents that can restore this interaction by screening natural small compound libraries via an IgG1-CD16a based ELISA assay. One lead compound was identified that was subsequently optimized by structural activity relationship analysis. This compound, named NAV-201, specifically binds CD16a and enhances the affinity of antibody binding to both the low affinity CD16a-158F and high affinity CD16a-158V allotypes. Moreover, we found that NAV-201 can also bind to the mouse CD16a ortholog and enhance its antibody binding affinity, making NAV-201 suitable for efficacy testing in mouse models. In vivo, NAV-201 was found to be well tolerated up to at least 120 mg/kg when administered orally and daily to mice, have a serum half-life of 18 hours, enhance systemic levels of the NK cell produced INF-γ and TNF-α cytokines, and enhance the therapeutic efficacy of antibodies in mouse xenografts. Together, these data support the further development of NAV-201 for human testing to improve and/or enhance the efficacy of antibody-based therapies in HIO factor positive cancers. Citation Format: Nicholas C. Nicolaides, Luigi Grasso, J. Brad Kline. NAV-201, an orally bioavailable small molecule NK cell activator enhancing antibody-mediated cancer therapies [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2024; Part 1 (Regular Abstracts); 2024 Apr 5-10; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2024;84(6_Suppl):Abstract nr 1345.
Read moreCharacterization of Linear IgE-Binding Epitopes in Food Allergens.
An IgE epitope is a part of an allergen that is capable of binding to IgE antibodies and eliciting an immune response. Identifying and characterizing human-allergy-relevant epitopes are important for diagnosis and prognosis of food allergy and development of immunotherapy treatments. This chapter describes the protocol for manual synthesis of overlapping peptides on a cellulose membrane and subsequent dot blotting of the peptides with allergic patients' IgE to map the linear IgE-binding epitopes in food allergens.
Read moreValidation of a Mobile App-Based Visual Analog Scale for Appetite Measurement in the Real World: A Randomized Digital Clinical Trial.
There has been no validated digital tool for measuring appetite with a visual analog scale (VAS) through a mobile app using participants' smart phones for data collection in virtual settings. To fill the gap, we developed a digital VAS and conducted a digital cross-over clinical trial by comparing appetite responses measured by this digital tool versus paper-based VAS in 102 participants in a free-living environment. Participants consumed either a 230 or 460 kcal breakfast in randomized order in two virtual sessions, and their appetite was measured over the next 4 h using both tools. The results revealed no significant difference in hunger, fullness, satiety, or desire to eat measured by digital and paper VAS. Paper VAS resulted in a higher prospective consumption score than digital VAS; the difference (1.1 out of 100 points) was statistically significant but not practically relevant. Bland and Altman analysis also indicated consistency in the results from the two methods. In conclusion, digital VAS on a smart phone is a validated tool for appetite measurement in the real world; it provides a new way for researchers to leverage participants' mobile devices for appetite data collection in digital trials.
Read more